A roadblock to appropriately positioned neoepitopes involves epigenetic silencing of MHC components, and the ability of linoleate and butanoate metabolites to inhibit HDAC activity and to re–express MHC functional complexes at the surface of colon cancer cells is worthy of further investigation. The gene discussed is HDAC9; the disease is malignant colon neoplasm.